SEARCH RESULTS

330029 RESULTS

Artificial Chaperone Keeps Amyloid-Forming Protein in Check

RESEARCH NEWS 2013-12-27 Research News When researchers in the Diflunisal Trial Consortium gathered for a meeting last March, they had no idea what was in store. John Berk of Boston University reviewed their attempt to treat the rare disease familial amyloid polyneuropathy (FAP)

CD33

ALZPEDIA CD33 is a transmembrane receptor of the innate immune system that is expressed on the surface of peripheral monocytes and microglial cells in the brain. CD33 was first implicated in Alzheimer’s disease genetics in 2008, and in 2011 reached genome-wide sig

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE